Editorial · 31 Dec 2025
Conference abstractPublished 2017
Management of hypertriglyceridemia in uncontrolled type-2 diabetes mellitus patients: 2 case studies
Dr. Sadi Konuk Training and Research Hospital, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: One of the known causes of hypertriglycerimidemia (HTG) is type-2 diabetes mellitus (DM). We aimed to present two uncontrolled type-2 DM associated with severe HTG who were treated succesfully with insulin infusion. Case 1: A thirty-two-year-old woman previously healthy was admitted to our outpatient clinic because of abdominal pain and polydipsia. Her physical examination was normal. Her laboratory investigations showed a fasting glucose (FG) 35 mg/dL, triglyceride (TGC) 1316 mg/dL, C-peptide 0.78 mg/dL, HbA1c% 14.7, pH: 7.35, ketonuria and glycosuria. Her serum amylase and lipase levels were 27 U/L and 26 U/L, respectively. There was no sign of acute pancreatitis (AP) on radiological examinations. Intravenous fluid therapy and continous insulin perfusion started to decrease glucose levels. With this treatment her TGC levels decreased as well. At 48th hour it dropped to 199 mg/dL. To exclude type-1 DM; insulin and anti GAD antibodies were negative. Later her glycemic control was continued with subcutaneous intensive insulin. After achieving glycemic control, she had no recurrence of HTG during her follow-up visits. Case 2: A second case of 52 years old woman with type-2 DM and severe HTG. Before 5 years she had an attack of AP (3 years after diagnosis of DM). Her FG, TGC and HbA1c were 393 mg/dL, 9283 mg/dL, and 14%, respectively. She also had ketonuria and glycosuria but no acidosis. AP attack was excluded and insulin infusion started. There was a progressive decrease in her TGC levels (380mg/dL at the 6th day of insulin treatment). Behind subcutaneous insulin therapy, omega 3 fatty acids and fibrate treatment were started too at discharge of hospital. After 3 months of follow-up, her TGC was 200 mg/dL. Conclusion: Lowering blood sugar in DM may lower the increased TGC levels as well. Bearing in mind this point may help in managing DM associated HTG.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Endocrinology & Diabetes Research.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalEndocrinology & Diabetes Research
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Betul Erismis”
- BylineArticles whose byline prints “Hatice Kaya”
- BylineArticles whose byline prints “Meral Mert”
